Michigan Medicine C.S. Mott Children’s Hospital

Ann Arbor, Michigan, USA
u-m mott.jpg

about this


C.S. Mott Children’s Hospital’s pediatric cancer specialists offer special expertise in caring for children with relapsed and resistant cancers.   Michigan Medicine is home to the largest pipeline of Phase 1 clinical trials in the state, with both Michigan-led and multi-site clinical trial offerings.

In addition, Michigan Medicine has developed one of the nation’s largest and most sophisticated gene sequencing programs, allowing for customization of treatment plans based on each child’s own genetic cancer profile.  Mott also has the largest, most experienced pediatric bone marrow transplant (BMT) program and cellular therapy program in the state of Michigan, from both a clinical and research standpoint.

Our pediatric oncologists are committed to a multidisciplinary and seamlessly coordinated approach to care, with collaboration across multiple disciplines through a single clinical home.  Innovative programs like the Chad Carr Pediatric Brain Tumor Center, our Solid Tumor Oncology Program and our pediatric brain tumor precision medicine meeting ensure that each patient benefits from the expertise of teams of dozens of specialists, consulting and advising on the care of each patient.


Alyssa Paul | Clinical Research Coordinator